$30,000 of BIODESIX INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare reimbursement for diagnostics. Medicare Contractor Reform. Lab test regulatory and reimbursement reform."
You can find more data on corporate lobbying on Quiver Quantitative.
BDSX Insider Trading Activity
BDSX insiders have traded $BDSX stock on the open market 21 times in the past 6 months. Of those trades, 6 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $BDSX stock by insiders over the last 6 months:
- JACK W SCHULER has made 6 purchases buying 8,372,029 shares for an estimated $3,928,046 and 0 sales.
- SCOTT HUTTON (President & CEO) has made 0 purchases and 3 sales selling 7,547 shares for an estimated $2,914.
- ROBIN HARPER COWIE (CFO, Sec'y & Treasurer) has made 0 purchases and 3 sales selling 1,980 shares for an estimated $764.
- KIERAN O'KANE (Chief Commercial Officer) has made 0 purchases and 3 sales selling 953 shares for an estimated $368.
- GARY ANTHONY PESTANO (Chief Development Officer) has made 0 purchases and 3 sales selling 887 shares for an estimated $342.
- CHRIS VAZQUEZ (Chief Accounting Officer) has made 0 purchases and 3 sales selling 452 shares for an estimated $174.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BDSX Hedge Fund Activity
We have seen 14 institutional investors add shares of BDSX stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AIGH CAPITAL MANAGEMENT LLC removed 4,272,591 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,205,725
- OPALEYE MANAGEMENT INC. removed 3,225,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $910,095
- SILVERARC CAPITAL MANAGEMENT, LLC removed 3,028,039 shares (-73.9%) from their portfolio in Q2 2025, for an estimated $854,512
- SAMJO MANAGEMENT, LLC removed 2,408,100 shares (-99.0%) from their portfolio in Q2 2025, for an estimated $679,565
- MONASHEE INVESTMENT MANAGEMENT LLC removed 2,050,000 shares (-50.6%) from their portfolio in Q2 2025, for an estimated $578,510
- FARALLON CAPITAL MANAGEMENT LLC removed 1,731,308 shares (-93.1%) from their portfolio in Q2 2025, for an estimated $488,575
- GSA CAPITAL PARTNERS LLP added 898,059 shares (+2694.0%) to their portfolio in Q2 2025, for an estimated $253,432
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BDSX Analyst Ratings
Wall Street analysts have issued reports on $BDSX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Scotiabank issued a "Sector Outperform" rating on 05/21/2025
- Craig-Hallum issued a "Buy" rating on 05/14/2025
- Lake Street issued a "Buy" rating on 05/14/2025
- Canaccord Genuity issued a "Buy" rating on 05/14/2025
To track analyst ratings and price targets for BDSX, check out Quiver Quantitative's $BDSX forecast page.
BDSX Price Targets
Multiple analysts have issued price targets for $BDSX recently. We have seen 4 analysts offer price targets for $BDSX in the last 6 months, with a median target of $2.0.
Here are some recent targets:
- Kyle Mikson from Canaccord Genuity set a target price of $20.0 on 09/19/2025
- Sung Ji Nam from Scotiabank set a target price of $2.0 on 05/21/2025
- Bill Bonello from Craig-Hallum set a target price of $1.5 on 05/14/2025
- Thomas Flaten from Lake Street set a target price of $2.0 on 05/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
